A multi-disciplinary team of senior physicians opted to use Zidebactam/Cefepime under compassionate use
The patient has been isolated in a designated hospital and is currently stable
Report highlights significant improvements in adolescent well-being in India
Multidisciplinary central team deployed to assist Gujarat with epidemiological, environmental, and laboratory investigations of AES cases
The company will address these observations within the stipulated timeline
States urged to maintain a state of constant vigil through screening of pregnant women for Zika virus infection and monitoring the growth of foetus of expecting mothers who tested positive for Zika
Phase I data for tuvusertib, lead asset from the company’s unique portfolio of DDR inhibitors
Fluid bed processes: drying, granulating, and coating in just one product container
Highly effective preservation solutions ensuring the safety and protection of personal care products
TALZENNA is the first and only PARP inhibitor approved in combination with standard of care XTANDI for mCRPC patients in the European Union
Subscribe To Our Newsletter & Stay Updated
